RadNet Inc
SWB:PQIA

Watchlist Manager
RadNet Inc Logo
RadNet Inc
SWB:PQIA
Watchlist
Price: 48.09 EUR 0.9%
Market Cap: €3.3B

EV/GP

10.6
Current
4%
More Expensive
vs 3-y average of 10.2

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
10.6
=
Enterprise Value
€4.4B
/
Gross Profit
$430.6m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
10.6
=
Enterprise Value
€4.4B
/
Gross Profit
$430.6m

Valuation Scenarios

RadNet Inc is trading above its 3-year average

If EV/GP returns to its 3-Year Average (10.2), the stock would be worth €46.36 (4% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-51%
Maximum Upside
No Upside Scenarios
Average Downside
28%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 10.6 €48.09
0%
3-Year Average 10.2 €46.36
-4%
5-Year Average 8.5 €38.7
-20%
Industry Average 5.2 €23.36
-51%
Country Average 6.5 €29.53
-39%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
US
RadNet Inc
SWB:PQIA
4.2B EUR 10.6 -228.8
US
CVS Health Corp
NYSE:CVS
105.9B USD 2.8 59.7
US
Cigna Group
XMUN:CGN
72.9B EUR 4.1 14.1
US
Cigna Corp
NYSE:CI
76.6B USD 0 12.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.2B EUR 5.6 18.4
DE
Fresenius Medical Care AG
XMUN:FME
22.4B EUR 5.8 22.8
US
Quest Diagnostics Inc
NYSE:DGX
21.6B USD 7 21.1
US
Laboratory Corporation of America Holdings
NYSE:LH
21.1B USD 6.4 24
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 3.4 11
US
Guardant Health Inc
NASDAQ:GH
11.4B USD 18.8 -27.3
US
DaVita Inc
NYSE:DVA
10.6B USD 4.5 14.2
P/E Multiple
Earnings Growth PEG
US
RadNet Inc
SWB:PQIA
Average P/E: 22
Negative Multiple: -228.8
N/A N/A
US
CVS Health Corp
NYSE:CVS
59.7
90%
0.7
US
C
Cigna Group
XMUN:CGN
14.1
19%
0.7
US
Cigna Corp
NYSE:CI
12.5
19%
0.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.4
25%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
22.8
15%
1.5
US
Quest Diagnostics Inc
NYSE:DGX
21.1
12%
1.8
US
Laboratory Corporation of America Holdings
NYSE:LH
24
27%
0.9
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11
15%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27.3 N/A N/A
US
DaVita Inc
NYSE:DVA
14.2
19%
0.7

Market Distribution

In line with most companies in the United States of America
Percentile
57th
Based on 9 428 companies
57th percentile
7.8
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

RadNet Inc
Glance View

RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis. Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.

PQIA Intrinsic Value
38.08 EUR
Overvaluation 21%
Intrinsic Value
Price €48.09
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett